January 11, 2017
Japanese generic major Nichi-Iko Pharmaceutical said on January 10 that its authorized generic (AG) of the antiplatelet agent Plavix (clopidogrel) has received approval for a new indication, trailing other clopidogrel generic makers to fill the last void with Sanofi’s originator...read more